NOTE 7 – STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)	1 Months Ended	2 Months Ended	5 Months Ended	6 Months Ended		10 Months Ended	12 Months Ended	18 Months Ended
	Jan. 19, 2023	Jun. 30, 2023	Jun. 06, 2023	Jun. 30, 2023	Jun. 29, 2023	Nov. 10, 2022	Dec. 31, 2022	Jun. 30, 2023	Nov. 07, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common Stock, Shares, Outstanding		79,825,094		79,825,094			74,108,926	79,825,094
Sale of Stock, Price Per Share		$ 0.20		$ 0.20				$ 0.20
Equity Incentive, shares									10,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period						4,250,000
Stock Issued During Period, Value, Stock Options Exercised	$ 500,000				$ 40,000	$ 425,000
Shares, granted	5,000,000		5,000,000					370,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number					750,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period					200,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number					550,000
Issued				180,000
Deferred Compensation Arrangement with Individual, Compensation Expense				$ 74,000
Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of Stock, Price Per Share							$ 0.10
Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of Stock, Price Per Share							$ 0.30
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock shares sold		336,168					2,080,085
Common stock shares sold							$ 334,913